HomeRYTM • NASDAQ
add
Rhythm Pharmaceuticals Inc
Previous close
$98.07
Day range
$90.84 - $97.81
Year range
$45.91 - $122.20
Market cap
6.19B USD
Avg Volume
660.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 57.25M | 36.87% |
Operating expense | 99.51M | 25.49% |
Net income | -47.50M | -9.73% |
Net profit margin | -82.97 | 19.84% |
Earnings per share | -0.73 | -1.39% |
EBITDA | -46.76M | -14.40% |
Effective tax rate | 0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 388.95M | 21.33% |
Total assets | 480.20M | 22.41% |
Total liabilities | 210.17M | -7.71% |
Total equity | 270.03M | — |
Shares outstanding | 67.21M | — |
Price to book | 47.38 | — |
Return on assets | -23.84% | — |
Return on capital | -34.46% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -47.50M | -9.73% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Nov 2008
Headquarters
Website
Employees
414
